Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Investing Articles

The AstraZeneca share price: 3 things UK investors should know now

| Rupert Hargreaves

I'm optimistic about the long-term potential of the AstraZeneca share price, thanks to these three tailwinds that should help the…

Read more »

Syringe and vial on blue background
Investing Articles

AstraZeneca shares: should I buy now?

| Edward Sheldon, CFA

AstraZeneca shares have done well in recent years, but have not risen on the Covid-19 vaccine news. Edward Sheldon looks…

Read more »

Syringe and vial on blue background
Investing Articles

Why is the AstraZeneca share price down nearly 8% this week?

| James J. McCombie

AstraZeneca's share price has fallen this week on concerns around the trial of the coronavirus vaccine it is developing with…

Read more »

Syringe and vial on blue background
Investing Articles

AstraZeneca shares: is the company a bargain after the vaccine candidate news?

| Jay Yao

Jay Yao discusses whether he thinks AstraZeneca is a bargain given the recent release of the company’s Covid-19 vaccine candidate…

Read more »

Investing Articles

At 8,000p, is FTSE 100 company AstraZeneca a share worth me buying right now?

| Kevin Godbold

If the R&D pipeline can keep powering yearly increases in earnings near 26%, as forecast for next year, I reckon…

Read more »

Investing Articles

AstraZeneca share price: Here’s my verdict after the Covid-19 vaccine news

| Jabran Khan

Jabran Khan provides his verdict on the AstraZeneca share price amid the recent Covid-19 vaccine breakthrough and recent performance.

Read more »

Investing Articles

Covid-19 vaccine: 1 biotech stock that profits from AstraZeneca’s success

| Zaven Boyrazian, MSc

Another Covid-19 vaccine may soon be available from AstraZeneca. Zaven Boyrazian analyses the results and finds a larger opportunity for…

Read more »

Investing Articles

AstraZeneca share price: 4 reasons I’d buy after its Covid-19 vaccine results

| Manika Premsingh

The AstraZeneca share price is down after it announced its Covid-19 vaccine results, but it’s unlikely to be affected much…

Read more »

Syringe and vial on blue background
Investing Articles

Should I buy AstraZeneca shares on vaccine news?

| Roland Head

AstraZeneca shares are up by 80% in five years. Roland Head's been taking a look at the pharma stock as…

Read more »

Live: Coronavirus Market Crash Coverage

Stock market rally: 2 dirt-cheap UK shares I’d buy today and hold forever

| Royston Wild

I reckon these exciting UK shares could help me get extremely rich with my Stocks and Shares ISA. I think…

Read more »

Investing Articles

The AstraZeneca share price nears its all-time high! Here’s what I’d do now

| Zaven Boyrazian, MSc

Zaven Boyrazian breaks down the latest results from AstraZeneca to decide whether the share price is justified or pure speculation.

Read more »

Investing Articles

2 stocks I wouldn’t want to own in a stock market crash

| Rachael FitzGerald-Finch

It's good to be prepared for a stock market crash. Here are two shares this Fool is avoiding in her…

Read more »